Barclays PLC Teva Pharmaceutical Industries LTD Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 04, 2023	BUY	$8.36 - $11.37 $659,604 - $897,092	78,900 New	78,900 $698,000
Q3 2021 Nov 09, 2021	SELL	$8.38 - $10.18 $2.24 Million - $2.72 Million	-267,000 Reduced 84.23%	50,000 $487,000
Q3 2020 Nov 12, 2020	SELL	$8.57 - $12.69 $797,010 - $1.18 Million	-93,000 Reduced 22.68%	317,000 $2.86 Million
Q2 2020 Aug 12, 2020	SELL	$8.12 - $13.12 $7.81 Million - $12.6 Million	-962,100 Reduced 70.12%	410,000 $5.06 Million
Q1 2020 May 13, 2020	SELL	$6.69 - $13.45 $4 Million - $8.04 Million	-598,000 Reduced 30.35%	1,372,100 $12.3 Million
Q4 2019 Feb 10, 2020	BUY	$6.53 - $10.72 $5.12 Million - $8.4 Million	783,900 Added 66.08%	1,970,100 $19.3 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $1.19 Million - $1.86 Million	193,900 Added 19.54%	1,186,200 $8.16 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $5.15 Million - $9.96 Million	633,800 Added 176.79%	992,300 $9.16 Million
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $10.5 Million - $13.5 Million	-675,500 Reduced 65.33%	358,500 $5.62 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $1.16 Million - $1.9 Million	79,700 Added 8.35%	1,034,000 $15.9 Million
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $2.59 Million - $3.16 Million	-123,200 Reduced 11.43%	954,300 $20.6 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $4.97 Million - $7.32 Million	-296,100 Reduced 21.56%	1,077,500 $26.2 Million
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $3.35 Million - $4.44 Million	201,100 Added 17.15%	1,373,600 $23.5 Million
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $3.13 Million - $5.32 Million	-278,700 Reduced 19.2%	1,172,500 $22.2 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $22.4 Million - $46.7 Million	1,451,200	1,451,200 $25.5 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$959 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$809 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$771 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$644 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$592 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account